James Beck
Medical Oncology · du Bois, PANPI 1114955085
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.2% of the total across 72 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 20.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $889 and has fallen 76.0% since, to $213 in 2025. That places this record below the midpoint for medical oncology clinicians in PA, where the typical reported total is $2,595.
Across 72 payments — averaging $21.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$324
- Novartis$227
- AstraZeneca$137
- Johnson & Johnson$113
- Astellas Pharma US Inc$109
- Bayer$94
- plus $544 from 19 others
What the payments were for
- Food & beverage$1,53599%
- Education$121%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 15 | $324 |
| Novartis | 5 | $227 |
| AstraZeneca | 2 | $137 |
| Johnson & Johnson(2 entities) | 7 | $113 |
| Astellas Pharma US Inc | 6 | $109 |
| Bayer | 6 | $94 |
| AbbVie | 5 | $90 |
| Amgen | 4 | $59 |
| E.r. Squibb & Sons, L.L.C. | 2 | $55 |
| Puma Biotechnology, Inc. | 2 | $40 |
| Boehringer Ingelheim | 2 | $38 |
| Merck | 3 | $35 |
| Recordati_rare_diseases_inc. | 1 | $30 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $23 |
| Tactile Systems Technology Inc | 1 | $22 |
| Lilly USA, LLC | 1 | $21 |
| Foundation Medicine, Inc. | 1 | $20 |
| Rigel Pharmaceuticals, Inc. | 1 | $20 |
| Kyowa Kirin, Inc. | 1 | $16 |
| Pfizer | 1 | $16 |
| Incyte Corporation | 1 | $15 |
| Regeneron Healthcare Solutions, Inc. | 1 | $13 |
| AMAG Pharmaceuticals, Inc. | 1 | $12 |
| Taiho Oncology, Inc. | 1 | $11 |
| Phadia US Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,547 in reported general payments places this provider in the 40th percentile of 238 medical oncology providers in Pennsylvania.
Other medical oncology in du Bois
- Carl JunePhiladelphia$9M
- Adam BrufskyPittsburgh$1.3M
- Sramila AithalBensalem$682K
- Shayma KazmiPhiladelphia$619K
- Deric SaviorWynnewood$343K
- Marcia BrosePhiladelphia$260K
- Adam CohenPhiladelphia$239K
- Daniel HallerPhiladelphia$227K
- Edith MitchellPhiladelphia$220K
- Elizabeth PlimackPhiladelphia$190K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.